These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
535 related articles for article (PubMed ID: 35393541)
1. Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities. Laumont CM; Banville AC; Gilardi M; Hollern DP; Nelson BH Nat Rev Cancer; 2022 Jul; 22(7):414-430. PubMed ID: 35393541 [TBL] [Abstract][Full Text] [Related]
2. B cells in the tumor microenvironment: Multi-faceted organizers, regulators, and effectors of anti-tumor immunity. Laumont CM; Nelson BH Cancer Cell; 2023 Mar; 41(3):466-489. PubMed ID: 36917951 [TBL] [Abstract][Full Text] [Related]
3. Antigen-Presenting Intratumoral B Cells Affect CD4 Bruno TC; Ebner PJ; Moore BL; Squalls OG; Waugh KA; Eruslanov EB; Singhal S; Mitchell JD; Franklin WA; Merrick DT; McCarter MD; Palmer BE; Kern JA; Slansky JE Cancer Immunol Res; 2017 Oct; 5(10):898-907. PubMed ID: 28848053 [TBL] [Abstract][Full Text] [Related]
4. Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8 Hladíková K; Koucký V; Bouček J; Laco J; Grega M; Hodek M; Zábrodský M; Vošmik M; Rozkošová K; Vošmiková H; Čelakovský P; Chrobok V; Ryška A; Špíšek R; Fialová A J Immunother Cancer; 2019 Oct; 7(1):261. PubMed ID: 31623665 [TBL] [Abstract][Full Text] [Related]
5. Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma. Maibach F; Sadozai H; Seyed Jafari SM; Hunger RE; Schenk M Front Immunol; 2020; 11():2105. PubMed ID: 33013886 [TBL] [Abstract][Full Text] [Related]
6. Checkpoint blockade immunotherapy enhances the frequency and effector function of murine tumor-infiltrating T cells but does not alter TCRβ diversity. Kuehm LM; Wolf K; Zahour J; DiPaolo RJ; Teague RM Cancer Immunol Immunother; 2019 Jul; 68(7):1095-1106. PubMed ID: 31104075 [TBL] [Abstract][Full Text] [Related]
7. Prognostic Landscape of Tumor-Infiltrating T and B Cells in Human Cancer. Zheng M; Li YM; Liu ZY; Zhang X; Zhou Y; Jiang JL; Zhu P; Yang XM; Tang J; Chen ZN Front Immunol; 2021; 12():731329. PubMed ID: 35069521 [TBL] [Abstract][Full Text] [Related]
8. Reduction of immunosuppressive tumor microenvironment in cholangiocarcinoma by ex vivo targeting immune checkpoint molecules. Zhou G; Sprengers D; Mancham S; Erkens R; Boor PPC; van Beek AA; Doukas M; Noordam L; Campos Carrascosa L; de Ruiter V; van Leeuwen RWF; Polak WG; de Jonge J; Groot Koerkamp B; van Rosmalen B; van Gulik TM; Verheij J; IJzermans JNM; Bruno MJ; Kwekkeboom J J Hepatol; 2019 Oct; 71(4):753-762. PubMed ID: 31195061 [TBL] [Abstract][Full Text] [Related]
9. Potential role of tumor-infiltrating T-, B-lymphocytes, tumor-associated macrophages and IgA-secreting plasma cells in long-term survival in the rectal adenocarcinoma patients. Zinovkin DA; Kose SY; Nadyrov EA; Achinovich SL; Los' DM; Gavrilenko TE; Gavrilenko DI; Yuzugulen J; Pranjol MZI Life Sci; 2021 Dec; 286():120052. PubMed ID: 34656554 [TBL] [Abstract][Full Text] [Related]
10. Tumor-infiltrating lymphocytes in the immunotherapy era. Paijens ST; Vledder A; de Bruyn M; Nijman HW Cell Mol Immunol; 2021 Apr; 18(4):842-859. PubMed ID: 33139907 [TBL] [Abstract][Full Text] [Related]
11. Clinical Significance of Tumour-Infiltrating B Lymphocytes (TIL-Bs) in Breast Cancer: A Systematic Literature Review. Lam BM; Verrill C Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831506 [TBL] [Abstract][Full Text] [Related]
12. Novel tumour-infiltrating lymphocyte-related risk stratification based by flow cytometry for patients with de novo angioimmunoblastic T cell lymphoma. Zhu Q; Deng X; Yao W; Chen Z; Ye Y; Gao L; Zhang W; Liu W; Zhao S Ann Hematol; 2021 Mar; 100(3):715-723. PubMed ID: 33389024 [TBL] [Abstract][Full Text] [Related]
13. Cellular characteristics of peripheral blood lymphocytes and tumour-infiltrating lymphocytes in patients with gynaecological tumours. Schöndorf T; Engel H; Lindemann C; Kolhagen H; von Rücker AA; Mallmann P Cancer Immunol Immunother; 1997 Apr; 44(2):88-96. PubMed ID: 9177470 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of tumour infiltrating B lymphocytes in breast ductal carcinoma in situ. Miligy I; Mohan P; Gaber A; Aleskandarany MA; Nolan CC; Diez-Rodriguez M; Mukherjee A; Chapman C; Ellis IO; Green AR; Rakha EA Histopathology; 2017 Aug; 71(2):258-268. PubMed ID: 28326600 [TBL] [Abstract][Full Text] [Related]
15. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas. Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905 [TBL] [Abstract][Full Text] [Related]
16. GITR ligation enhances functionality of tumor-infiltrating T cells in hepatocellular carcinoma. van Beek AA; Zhou G; Doukas M; Boor PPC; Noordam L; Mancham S; Campos Carrascosa L; van der Heide-Mulder M; Polak WG; Ijzermans JNM; Pan Q; Heirman C; Mahne A; Bucktrout SL; Bruno MJ; Sprengers D; Kwekkeboom J Int J Cancer; 2019 Aug; 145(4):1111-1124. PubMed ID: 30719701 [TBL] [Abstract][Full Text] [Related]
17. Prognostic Significance of Tumor-Infiltrating B Cells and Plasma Cells in Human Cancer. Wouters MCA; Nelson BH Clin Cancer Res; 2018 Dec; 24(24):6125-6135. PubMed ID: 30049748 [TBL] [Abstract][Full Text] [Related]
18. Computational recognition of lncRNA signature of tumor-infiltrating B lymphocytes with potential implications in prognosis and immunotherapy of bladder cancer. Zhou M; Zhang Z; Bao S; Hou P; Yan C; Su J; Sun J Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32382761 [TBL] [Abstract][Full Text] [Related]
19. Tumour-infiltrating lymphocytes and the emerging role of immunotherapy in breast cancer. Luen SJ; Savas P; Fox SB; Salgado R; Loi S Pathology; 2017 Feb; 49(2):141-155. PubMed ID: 28049579 [TBL] [Abstract][Full Text] [Related]
20. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma. Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]